# Human Albumin for Clinical Outcome in Aneurysmal Subarachnoid Hemorrhages

> **NCT06548477** · NA · RECRUITING · sponsor: **Hamad Medical Corporation** · enrollment: 84 (estimated)

## Conditions studied

- Aneurysmal Subarachnoid Hemorrhage

## Interventions

- **DRUG:** Human albumin

## Key facts

- **NCT ID:** NCT06548477
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2024-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06548477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06548477, "Human Albumin for Clinical Outcome in Aneurysmal Subarachnoid Hemorrhages". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06548477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*